Gene Therapy for GM1 Gangliosidosis Mediated by AAV Vector Carrying BBB-Penetrable Enzyme

被引：0

作者：

Matsushima, Saki ^{[1
]}

Iizuka, Sayoko ^{[1
]}

Kinoshita, Masafumi ^{[2
]}

Takagi, Haruna ^{[2
]}

Iizuka, Shunsuke ^{[2
]}

Ohtsuki, Kota ^{[2
]}

Imakiire, Atsushi ^{[2
]}

Nagashima, Takashi ^{[3
]}

Okamoto, Shinichiro ^{[4
,5
]}

Higuchi, Takashi ^{[1
]}

Shimada, Yohta ^{[1
]}

Hioki, Hiroyuki ^{[4
]}

Sonoda, Hiroyuki ^{[2
]}

Watabe, Ayako M. ^{[3
]}

Ohashi, Toya ^{[6
]}

Kobayashi, Hiroshi ^{[1
]}

机构：

[1] Jikei Univ, Div Gene Therapy, Res Ctr Med Sci, Sch Med, Tokyo, Japan

[2] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan

[3] Jikei Univ, Inst Clin Med & Res, Res Ctr Med Sci, Sch Med, Chiba, Japan

[4] Juntendo Univ, Dept Neuroanat, Grad Sch Med, Tokyo, Japan

[5] Juntendo Univ, Adv Res Inst Hlth Sci, Tokyo, Japan

[6] Jikei Univ, Sch Nursing, Tokyo, Japan

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1344

引用

页码：635 / 636

页数：2

共 50 条

[21] Adeno-Associated Viral (AAV) Vector-Mediated GLB1 Gene Transfer Reduces Substrate Accumulations in a Murine Model of GM1 Gangliosidosis
Ni, Yan G.
Gelb, Michael
Herbst, Zachary
Vrentas, Catherine
Messick, Elyse
Weinstein, David A.
Browne, Susan E.
Wilson, James M.
Hinderer, Christian
MOLECULAR THERAPY, 2023, 31 (04) : 388 - 388
[22] Investigational AAV Gene Therapy LYS-GM101 for GM1-Gangliosidosis
Hocquemiller, Michael
Olivier, Sophie
Parker, Samantha
Aiach, Karen
Laufer, Ralph
MOLECULAR THERAPY, 2020, 28 (04) : 562 - 563
[23] IV Gene Therapy Corrects Feline GM1 Gangliosidosis Long Term
Edwards, Heather
Randle, Ashley
Sena-Esteves, Miguel
Martin, Douglas
MOLECULAR THERAPY, 2016, 24 : S144 - S145
[24] Development of a Hematopoietic Stem Cell Gene Therapy for Infantile GM1 Gangliosidosis
Bucciarelli, Linda
Fabris, Camilla
Scarabello, Elena
Accardo, Massimo
Poletti, Valentina
Biffi, Alessandra
MOLECULAR THERAPY, 2024, 32 (04) : 733 - 734
[25] Mesenchymal stem cell and lentiviral gene therapy for feline GM1 gangliosidosis
Martin, DR
Haack, K
Krum, BK
Hathcock, TL
Cox, NR
Kafri, T
Niemeyer, GP
Baker, HJ
MOLECULAR THERAPY, 2003, 7 (05) : S253 - S253
[26] Phase 1/2 trial of AXO-AAV-GM1 (AAV9-GLB1) gene therapy for infantile- and juvenile-onset GM1 gangliosidosis
Tifft, Cynthia
D'Souza, Precilla
Johnston, Jean M.
Acosta, Maria T.
Nicoli, Elena-Raluca
Rothermel, Caroline
Thurm, Audrey
Karunakara, Ajith
Thorp, Benjamin
Ross, Peter
Jameson, John
Sheehan, Michael
Vaughn, Toby
Valencia, Donna
De Boever, Erika
Corcoran, Gavin
MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S119 - S119
[27] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis
Tifft, C.
D'Souza, P.
Johnston, J. M.
Acosta, M. T.
Nicoli, E. R.
Rothermel, C.
Thurm, A.
Karunakara, A.
Thorp, B.
Ross, P.
Jameson, J.
Sheehan, M.
Vaughn, T.
Valencia, D.
De Boever, E.
Corcoran, G.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A11 - A12
[28] A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis
Tift, Cynthia
D'Souza, Precilla
Johnston, Jean
Acosta, Maria
Nicoli, Elena-Raluca
Rothermel, Caroline
Thurm, Audrey
Karunakara, Ajith
Thorp, Benjamin
Ross, Peter
Jameson, John
Sheehan, Michael
Vaughn, Toby
Valencia, Donna
De Boever, Erika
GENETICS IN MEDICINE, 2022, 24 (03) : S164 - S164
[29] Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies
Hosseini, Kamran
Fallahi, Jafar
Tabei, Seyed M. B.
Razban, Vahid
CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (08) : 1093 - 1105
[30] ENZYME HISTOCHEMICAL AND ULTRASTRUCTURAL FEATURES OF BOVINE GM1 GANGLIOSIDOSIS
SHEAHAN, BJ
DONNELLY, WJC
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1975, 1 (03) : 317 - 317

← 1 2 3 4 5 →